KFDA Takes Detailed Safety Review on Celebrex

The Korea Food and Drug Administration (KFDA) announced that it is taking a detailed safety review on Pfizer’s Celebrex, reflecting the U.S. Food and Drug Administration (FDA)’s recent citation on the safety issues of Celebrex from the study conducted by the U.S. National Cancer Institute (NCI).

An official from the KFDA said, “Many countries including the United States are carefully reviewi...